About PENBRAYA™
(Meningococcal Groups A, B, C, W, and Y Vaccine)
PENBRAYA protection
PENBRAYA is the only FDA-approved vaccine that helps protect your teen from all 5 leading types of meningococcal meningitis—A, B, C, W, and Y—with fewer shots. PENBRAYA combines 2 meningitis vaccines that have helped protect teens for nearly 10 years.*
One vaccine protects against types A, C, W, and Y and the other against type B.
When should my teen get PENBRAYA?
Help protect your teen from all 5 leading types of meningococcal meningitis with 1 less required shot. By vaccinating your healthy teen with PENBRAYA at age 16, they can:
- complete their vaccination against types A, C, W, and Y
- begin their vaccination for type B
Safety profile
The safety of PENBRAYA was researched in 3 clinical studies. 2306 participants ranging in age from 10 to 25 years received at least 1 dose of PENBRAYA.
The studies compared how participants’ immune systems responded following vaccination with:
or
An existing vaccine for types A, C, W, and Y
An existing vaccine for type B
Participants experienced similar side effects whether they received PENBRAYA or the 2 existing vaccines.
The most common side effects were pain at the injection site, fatigue, headache, muscle pain, injection site redness, injection site swelling, joint pain, and chills.
Is your teen protected against all 5 leading types of meningococcal meningitis?
Use our discussion guide to start a conversation with your teen’s doctor.